🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
Within this exploratory multicohort phase II trial, SAKK aims to evaluate a...
Status
Active Not Recruiting
Location
Ospedale Papa Giovanni XXIII
Start Date
2021-06-25
Trial ID
NCT04604067
Treatments Being Tested
This study is a treatment protocol with blinatumomab for infants under 1 ye...
Status
Recruiting
Location
Hospital de Pediatría S.A.M.I.C. "Juan P. Garrahan"
Start Date
2022-12-15
Trial ID
NCT05327894
Treatments Being Tested
The objective of this study is to investigate if low doses of prednisone MR...
Status
Completed
Location
Research Site
Start Date
2004-08-31
Trial ID
NCT00146640
Treatments Being Tested
This randomized phase III trial is studying cyclophosphamide, prednisone, a...
Status
Completed
Location
Children's Hospital of Alabama
Start Date
2004-03-15
Trial ID
NCT00033293
This phase II/III trial tests adding glofitamab to standard of care chemoim...
Status
Not Yet Recruiting
Location
Multiple Locations
Start Date
2026-10-30
Trial ID
NCT07724457
Treatments Being Tested
This phase II trial tests how well abiraterone acetate/niraparib (CJNJ-6765...
Status
Terminated
Location
Mayo Clinic in Arizona
Start Date
2024-03-05
Trial ID
NCT05689021
This phase III trial compares the effect of adding immunotherapy (brentuxim...
Status
Recruiting
Location
Children's Hospital of Alabama
Start Date
2023-05-11
Trial ID
NCT05675410
Treatments Being Tested
This phase III trial studies whether inotuzumab ozogamicin added to post-in...
Status
Recruiting
Location
Children's Hospital of Alabama
Start Date
2019-10-31
Trial ID
NCT03959085
Treatments Being Tested
Patients are in 2 cohorts: Cohort 1: dexamethasone, methotrexate, ifosfami...
Status
Recruiting
Location
University of Alabama
Start Date
2019-03-01
Trial ID
NCT03719105
This phase II trial studies the side effects and how well blinatumomab and ...
Status
Active Not Recruiting
Location
University of Alabama at Birmingham Cancer Center
Start Date
2015-06-30
Trial ID
NCT02143414